Costs associated with renal and cardiovascular events among patients with type 2 diabetes mellitus and nephropathy: a cost model based on the CREDENCE clinical trial-Reference-Cited by-同舟云学术

Costs associated with renal and cardiovascular events among patients with type 2 diabetes mellitus and nephropathy: a cost model based on the CREDENCE clinical trial

Published:2020-01-09 Issue:4 Volume:36 Page:563-570
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Manceur Ameur M.¹,Durkin Mike²,Kharat Akshay²,Bookhart Brahim²,Lafeuille Marie-Hélène¹,Pilon Dominic¹,Fakih Iman¹,Lefebvre Patrick¹

Affiliation:

1. Analysis Group, Inc, Montréal, Canada;

2. Janssen Scientific Affairs, LLC, Titusville, NJ, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2019.1708285

Reference32 articles.

1. Centers for Disease Control and Prevention (CDC) [Internet]. Type 2 Diabetes; 2019 [cited 2019 July 11]. Available from: https://www.cdc.gov/diabetes/basics/type2.html.

2. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2019

3. Type 2 diabetes mellitus

4. 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019

5. Prevalence of Cardiovascular Disease In Type 2 Diabetes: A Global Systematic Review

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic kidney disease in type 2 diabetes: The size of the problem, addressing residual renal risk and what we have learned from the CREDENCE trial;Diabetes, Obesity and Metabolism;2024-07-23

2. Cost Offset of Dapagliflozin in the US Medicare Population with Cardio-Kidney Metabolic Syndrome;Advances in Therapy;2024-07-03

3. Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes;Cochrane Database of Systematic Reviews;2024-05-21

4. Translating the efficacy of dapagliflozin in chronic kidney disease to lower healthcare resource utilization and costs: a medical care cost offset analysis;Journal of Medical Economics;2023-10-31

5. Analysis of reactive aldehydes in urine and plasma of type-2 diabetes mellitus patients through liquid chromatography-mass spectrometry: Reactive aldehydes as potential markers of diabetic nephropathy;Frontiers in Nutrition;2023-01-16